Assoc. Prof. ALİ ERDOĞAN

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (Scopus)

326

H-Index (Scopus)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Education

2012 - 2016

Doctorate

Akdeniz University, Faculty of Medicine, Psikiyatri, Turkey

2002 - 2008

Postgraduate

Akdeniz University, Faculty of Medicine, Turkey

Dissertations

2016

Expertise In Medicine

İntravenöz kullanımı olan ve olmayan opiyat bağımlısı hastalarda kişilik, mizaç özellikleri ve dürtüsellik düzeyleri

Akdeniz University, Dahili Tıp Bilimleri, Ruh Sağlığı Ve Hastalıkları

Foreign Languages

B2 Upper Intermediate

English

Certificates, Courses and Trainings

2021

Şizofreni Tedavisinde Uzmanlar İçin Psikoterapi Yöntemleri

Vocational Training

Murad Atmaca Psikoterapi Eğitim Merkezi

2021

İyi Klinik Uygulamalar Eğitimi

Quality Management

Akdeniz Üniversitesi

2021

Şema Terapi Eğitimi

Health&Medicine

PsikoNET Psikoterapi ve Eğitim Merkezi

2021

Cinsel Terapi Temel Eğitimi

Health&Medicine

CETAD

2016

Bilişsel Davranışçı Terapi Eğitimi

Health&Medicine

Türkiye Psikiyatri Derneği

Research Areas

Avesis Research Areas: Medicine, Internal Medicine Sciences, Psychiatry, Health Sciences

WoS Research Areas: Clinical Medicine (Med), Psychiatry, Psychology, Medical Ethics, Behavioral Sciences, Substance Abuse, Social Issues, Neuroscience & Behavior

Scopus Research Areas: General Psychology, Behavioral Neuroscience, Psychiatry and Mental Health

Research Areas Based on Academic Activities

Avesis Research Areas

WoS Research Areas

Scopus Research Areas

Academic Positions

2023 - Present

Administrative Staff

Akdeniz University, Faculty of Medicine, Department of Internal Medicine

2023 - Present

Associate Professor

Akdeniz University, Faculty of Medicine, Department of Internal Medicine

2022 - 2023

Assistant Professor

Akdeniz University, Faculty of Medicine, Department of Internal Medicine

2019 - 2022

Lecturer PhD

Akdeniz University, Faculty of Medicine, Department of Internal Medicine

Managerial Experience

2026 - Present

Member of the Faculty Board

Akdeniz University, Faculty Of Medicine, Department Of Internal Medicine

2026 - Present

Education and Curriculum Board Member

Akdeniz University

2026 - Present

Faculty Board Member

Akdeniz University, Faculty Of Medicine, Department Of Internal Medicine

2020 - Present

Postgraduate Education Responsible

Akdeniz University, Faculty Of Medicine, Department Of Internal Medicine

2023 - 2026

Head of Department

Akdeniz University, Faculty Of Medicine, Department Of Internal Medicine

2021 - 2025

Ethics Committee Member

Akdeniz University, Faculty Of Medicine, Department Of Internal Medicine

Non Academic Experience

2017 - 2019

Uzman Doktor

Other Public Institution, Ataköy Ruh Ve Sinir Hastalıkları Hastanesi/Trabzon, Uzman Doktor, Uzman Doktor

2008 - 2009

Hekim-Pratisyen

SAĞLIK BAKANLIĞI HINIS DEVLET HASTANESİ/ERZURUM, Hekim-Pratisyen

Courses

Expertise In Medicine

BİLİŞSEL DAVRANIŞÇI TERAPİ

NARKOLEPSİ

Esrar Kullanım Bozukluğu

Davranışsal Bağımlılıklar

Postgraduate

Kişilik Bozuklukları

Psikodinamik Psikiyatri

Alkol ve Madde Kullanım Bozzuklukları

Psikiyatrik Aciller

Undergraduate

PSİKİYATRİK ACİLLER

BAĞIMLI HASTAYA YAKLAŞIM

İNTİHAR DÜŞÜNCESİ GİRİŞİMİ / KENDİNE ZARAR

AGRESYONLA (SİNİRLİLİK) BAŞA ÇIKABİLME

Psikiyatrik Semiyoloji

Alkol ve Madde Kullanım Bozuklukları

PSİKİYATRİK ÖYKÜ ALMA

Somatoform Bozukluklar

PSİKODİNAMİK PSİKİYATRİ

Supervised Theses

2025

Expertise In Medicine

Rehabilitasyon hizmeti alan şizofreni hastalarında içgörü, içselleştirilmiş damgalanma, benlik saygısı ve sosyal işlevsellik

Erdoğan A. (Advisor)

B.ÖZKAYA(Student)

2024

Expertise In Medicine

Akıllı telefon bağımlılığının uyku kalitesi, yeme tutumu ve obezite ile ilişkisi

Erdoğan A. (Advisor)

D.DOLAŞ(Student)

Taught Courses and Trainings

2021 - 2021

Bağımlılıktan Korunma Yöntemleri

Academic Units - Training

Erdoğan A.

Articles

2026

1. Fibroblast Growth Factor-2 (FGF-2) and Fibroblast Growth Factor-9 (FGF-9) Levels in Patients With Opioid Use Disorder in Remission: Implications for Neuroplasticity

Erdoğan A.

JOURNAL OF DRUG ISSUES , vol.1, no.1, pp.1, 2026 (SSCI, Scopus)

2026

2. Impulsivity and aggression in patients with methamphetamine use disorder and opioid use disorder

KARABULUT S., ERDOĞAN A., Kuloğlu Z., DÜZGÜN M., KULAKSIZOĞLU B.

Journal of Substance Use , vol.31, no.1, pp.77-81, 2026 (SSCI, Scopus)

2025

3. Serum zonulin, brain-derived neurotrophic factor, and oxidative stress levels in individuals using paper (A4) impregnated with synthetic cannabinoids.

Kulaksızoğlu S., Erdoğan A., Tosun O., Görgülü Z. Y., Acar E., Kireç Y., et al.

Frontiers in psychiatry , vol.16, pp.1693270, 2025 (SCI-Expanded, SSCI, Scopus)

2025

4. The Relationship of Smartphone Addiction with Sleep Quality, Eating Attitudes, and Obesity

DOLAŞ D., COŞKUN M. N., ERDOĞAN A.

Addicta: the Turkish Journal on Addictions , vol.12, no.3, pp.324-330, 2025 (ESCI, Scopus, TRDizin)

2025

5. Bruxism and Sleep Disorders in Patients Diagnosed With Depressive Disorder and Anxiety Disorder Using Antidepressants

Avan G. N. P., ERDOĞAN A., CİNEMRE B., KULAKSIZOĞLU B., METİN Ö.

Journal of Oral Rehabilitation , vol.52, no.1, pp.57-63, 2025 (SCI-Expanded, Scopus)

2025

6. The impact of smartphone addiction and social media addiction on traffic safety

DÜZGÜN M., ERDOĞAN A., KARABULUT S., ŞAFAK E., Kuloğlu Z., Ongun H. İ., et al.

Journal of Public Health (Germany) , 2025 (ESCI, Scopus)

2025

7. Clinical factors associated with craving in patients with opioid use disorder receiving buprenorphine-naloxone maintenance therapy

ERDOĞAN A., KARABULUT S., Coşkun M. N., TOSUN O., TURAN ÖZTAŞ F. N., KARSAVURDAN F., et al.

Journal of Substance Use , 2025 (SSCI, Scopus)

2024

8. Childhood Traumas, Attachment Styles and Related Clinical Factors in Opioid Use Disorder

Topcuoğlu M., Coşkun M. N., ERDOĞAN A., KULAKSIZOĞLU B.

Noropsikiyatri Arsivi , vol.61, no.4, pp.339-344, 2024 (SCI-Expanded, Scopus, TRDizin)

2024

9. Sociodemographic and clinical characteristics of patients admitted to an addiction center with methamphetamine use

Erdoğan A.

JOURNAL OF SUBSTANCE ABUSE , vol.0, no.0, 2024 (SSCI)

2024

10. Comparative evaluation of craving, sleep quality, sexual function and quality of life in opioid use disorder patients in remission with buprenorphine/naloxone maintenance treatment

Türker Z. G., ERDOĞAN A., CİNEMRE B., METİN Ö., KULAKSIZOĞLU B.

Human Psychopharmacology , vol.39, no.6, 2024 (SCI-Expanded, Scopus)

2024

11. Frequency of Methamphetamine Use in Patients Admitted to an Addiction Center and Clinical Factors Associated With Methamphetamine Use

Erdoğan A., Karabulut S.

JOURNAL OF DRUG ISSUES , vol.0, 2024 (SSCI, Scopus)

2024

12. Exploring stigmatization in digital newspaper coverage of substance use disorder.

BİLİŞLİ Y., KESER İ., ERDOĞAN A., Çakmak F., KAYAN F., Saygın N.

Heliyon , vol.10, no.7, 2024 (SCI-Expanded, Scopus)

2024

13. Internalized Stigma and Traumatizing Effects of Psychiatric Hospitalization in Adolescents: Is There Any Difference Between Being Hospitalized in Adult or Adolescent Inpatient Psychiatric Services?

Akdağ B., Kopuz H. Y., ÖNDER A., SÜRER ADANIR A., Çoban Ö. G., Yıldırım Ö., et al.

Psychological Trauma: Theory, Research, Practice, and Policy , 2024 (SSCI, Scopus)

2024

14. Knowledge levels and attitudes of individuals regarding substance use disorder in Turkey

ERDOĞAN A., Kahya Y., YILMAZ Y., Edebali M. İ., Uğurlu M.

Journal of Substance Use , vol.29, no.6, pp.1145-1150, 2024 (SSCI)

2023

15. INVESTIGATION OF PREDICTIVE FACTORS FOR CLINICAL REMISSION IN RESPONSE TO REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) TREATMENT IN DEPRESSIVE DISORDER

ozcelik o., Cinemre B., Erdoğan A., metin ö.

Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi , vol.30, no.3, pp.344-352, 2023 (Peer-Reviewed Journal)

2023

16. Evaluation of Coronavirus Disease 2019-Related Anxiety, Depression, and Post-Traumatic Stress Disorder in Liver Transplantation Recipients and Their Caregivers

Adanir H., Erdogan A., ,

Cerrahpaşa Medical Journal , vol.47, no.2, pp.229-234, 2023 (TRDizin)

2023

17. The parental COVID-19 anxiety and emotional exhaustion in healthcare workers: exploring the roles of resilience, prosocialness, and optimism

Akdağ B., Ege D., GÖKSÜLÜK D., İpekten F., ERDOĞAN A., ÖNDER A.

Current Psychology , vol.42, no.23, pp.20042-20051, 2023 (SSCI, Scopus)

2023

18. LEVELS OF CYBERCHONDRIA, HEALTH ANXIETY AND INTERNET ADDICTION IN MEDICAL FACULTY STUDENTS

Calhan S., ERDOĞAN A.

Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi , vol.24, no.3, pp.300-304, 2023 (TRDizin)

2023

19. Second to fourth digit ratio (2D:4D), impulsivity and aggression levels in patients with opiate use disorder and alcohol use disorder

ERDOĞAN A., Özge B., KOPAN M., Aktan Y., KULAKSIZOĞLU B.

Journal of Substance Use , vol.28, no.6, pp.899-903, 2023 (SSCI, Scopus)

2023

20. Bir Üniversite Hastanesi Psikiyatri Kliniğinde Elektrokonvülsif Terapi Uygulanmış Hastaların Sosyodemografik ve Klinik Özelliklerinin Retrospektif Olarak İncelenmesi

Tıraş İ., Soğucak S., Erdoğan A., Kulaksızoğlu B.

Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi , vol.0, 2023 (TRDizin)

2022

21. EXPERIENCES OF WOMEN WITH SUBSTANCE USE DISORDER REGARDING THE PREGNANCY PROCESS

YALNIZ DİLCEN H., BİLİŞLİ Y., ERDOĞAN A.

THE JOURNAL OF WORLD WOMEN STUDIES , vol.7, no.1, pp.89-98, 2022 (Peer-Reviewed Journal)

2022

22. Comparison of Pet Owners and Non-Pet Owners in Terms of Depression, Anxiety and Quality of Life

ERDOĞAN A., KAHYA Y.

Genel Tıp Dergisi , vol.32, no.5, pp.484-487, 2022 (TRDizin)

2022

23. Repetitive Transcranial Magnetic Stimulation in a Group of Treament-Resistant Obsessive-Compulsive Disorder Patients: A Descriptive Study

Topcuoğlu M., Cinemre B., Erdoğan A., Nabiyeva N.

Acta Medica , vol.53, no.2, pp.114-122, 2022 (TRDizin)

2022

24. Comparison of naltrexone implant and oral buprenorphine-naloxone in the treatment of opiate use disorder.

ERDOĞAN A., TOPCUOĞLU M., COŞKUN M. N., CİNEMRE B., KULAKSIZOĞLU B., KULOĞLU M. M.

Human psychopharmacology , vol.37, no.2, 2022 (SCI-Expanded, Scopus)

2022

25. Comparison of Patients with Schizophrenia, Bipolar Disorder, and Substance Use Disorder in Terms of Family Burden

Kahya Y., Erdoğan A., Önder A., Kulaksızoğlu B., Kulağlu M. M.

The Turkish Journal on Addictions , vol.1, no.1, pp.1-9, 2022 (ESCI)

2022

26. The relationship of remission with functionality, quality of life and craving in patients with opiate use disorder Opiyat kullanim bozukluǧu olan hastalarda remisyonun işlevsellik, yaşam kalitesi ve aşerme ile ilişkisi

BALCI M. M., Pak S. C., ERDOĞAN A., ERYILMAZ M. M.

Klinik Psikiyatri Dergisi , vol.25, no.1, pp.67-74, 2022 (ESCI, Scopus, TRDizin)

2022

27. Risperidone-Associated Acute Laryngeal Dystonia A Case Report

ERDOĞAN A., İLHAN F.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , vol.42, no.1, pp.98-99, 2022 (SCI-Expanded, Scopus)

2022

28. A Comparison of Buprenorphine/Naloxone and Extended-Release Naltrexone Treatments in Terms of Sleep Quality, Sexual Life, Eating Behavior, and Quality of Life in Patients with Opiate Use Disorder

BIDI T., ERDOĞAN A., CİNEMRE B., KULAKSIZOĞLU B.

ADDICTA-THE TURKISH JOURNAL ON ADDICTIONS , 2022 (TRDizin)

2022

29. Sociodemographic and clinical characteristics of patients admitted to an addiction center

ERDOĞAN A., Dilcen H. Y., CİNEMRE B., KULAKSIZOĞLU B., İNAN D., Kuloglu M. M.

JOURNAL OF SUBSTANCE USE , vol.27, no.3, pp.321-327, 2022 (SSCI, Scopus)

2022

30. Vitaminlerin psikiyatrideki rolü: Bir gözden geçirme

YILMAZ Y., ERDOĞAN A., HOCAOĞLU Ç.

Troia Medical Journal , vol.3, no.1, pp.1-9, 2022 (Peer-Reviewed Journal)

2022

31. Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Comorbid Nicotine Addiction with Major Depressive Disorder and Obsessive-Compulsive Disorder

YAŞAR A. U., CİNEMRE B., ERDOĞAN A.

BAGIMLIK DERGISI , vol.23, no.3, pp.275-282, 2022 (Peer-Reviewed Journal)

2021

32. Fear, Anxiety, Burnout, and Insomnia Levels of Healthcare Workers during COVID-19 Pandemic in Turkey.

Yılmaz Y., Erdoğan A., Bahadır E.

Psychiatria Danubina , vol.33, no.Suppl 13, pp.350-356, 2021 (SCI-Expanded, SSCI, Scopus)

2021

33. Serum hepcidin / ferroportin levels in bipolar disorder and schizophrenia

Altun I. K., Atagun M. I., ERDOĞAN A., Yenilmez D. O., Yusifova A., Senat A., et al.

JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY , vol.68, 2021 (SCI-Expanded, Scopus)

2021

34. Validity and Reliability Study of the Childbirth Trauma Index.

Dilcen H. Y., Türkmen H. Y., Erdoğan A.

Journal of nursing measurement , 2021 (ESCI, Scopus)

2021

35. Dermatosis due to Methamphetamine Use: A Case Report

TOPCUOĞLU M., ERDOĞAN A., KULAKSIZOĞLU B.

ADDICTA-THE TURKISH JOURNAL ON ADDICTIONS , vol.8, no.2, pp.157-159, 2021 (ESCI, TRDizin)

2021

36. The relationship of serum leptin and ghrelin levels with craving and withdrawal in opioid use disorder

KARA H., ERDOĞAN A., Akbas H., KULOĞLU M. M.

Anadolu Psikiyatri Dergisi , vol.22, no.4, pp.200-205, 2021 (Scopus, TRDizin)

2021

37. Follow-up of serum naltrexone levels after naltrexone implant in opioid use disorder

KULAKSIZOĞLU B., ERDOĞAN A., CİNEMRE B., TOPCUOĞLU M., COŞKUN M. N., Ozdemir M., et al.

Heroin Addiction and Related Clinical Problems , vol.23, no.3, pp.23-28, 2021 (SSCI, Scopus)

2021

38. Frequency of HBV, HCV and HIV Infections and Determination of HCV Genotype Distribution in People who Inject Drugs

Kara H., İNAN D., ÖZÇELİK Ö., ERDOĞAN A., ÇOLAK D., ÖNGÜT G.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.27, no.1, pp.19-23, 2021 (ESCI)

2021

39. Suicidal major depression in a healthcare worker associated with the covid-19 pandemic: A case report Bir sağlık çalışanında covid-19 pandemisi ile ilişkili intihar düşüncesinin eşlik ettiği majör depresyon: Olgu sunumu

PALA G. N., CİNEMRE B., ERDOĞAN A.

Duzce Medical Journal , vol.23, no.1, pp.116-118, 2021 (Scopus)

2021

40. Investigation of the relationships between cybercondria, anxiety sensitivity, somatosensory amplification, and intolerance to uncertainty Siberkondria, anksiyete duyarlılığı, bedensel duyumları abartma ve belirsizliğe tahammülsüzlük arasındaki ilişkilerin incelenmesi

Yılmaz Y., Bahadır E., ERDOĞAN A.

Klinik Psikiyatri Dergisi , vol.24, no.4, pp.450-458, 2021 (ESCI, Scopus, TRDizin)

2021

41. Attitude of Psychiatry Clinic Patients Towards Digital Health Applications with Internet and Smartphone Usage

CİNEMRE B., COŞKUN M. N., TOPCUOĞLU M., ERDOĞAN A.

Kocaeli Tıp Dergisi , vol.10, no.2, pp.147-155, 2021 (TRDizin)

2021

42. Evaluation of Internet Gaming Disorder, Social Media Addiction, and Levels of Loneliness in Adolescents and Youth with Substance Use.

Turhan Gürbüz P., Gizli Çoban Ö., Erdoğan A., Yazıcı Kopuz H., Sürer Adanır A., Önder A.

Substance use & misuse , vol.56, no.12, pp.1874-1879, 2021 (SCI-Expanded, SSCI, Scopus)

2021

43. The new disease of the modern age: What is the fear of missing out “fomo”? a review Modern çağın yeni hastalığı: Gelişmeleri kaçırma korkusu “fomo” nedir? bir gözden geçirme

Erdoğan A., Yılmaz Y., HOCAOĞLU Ç.

Cyprus Turkish Journal of Psychiatry and Psychology , vol.3, no.3, pp.217-222, 2021 (Scopus)

2021

44. Dermatosis Due to Methamphetamine Use: A Case Report

TOPCUOĞLU M., ERDOĞAN A., KULAKSIZOĞLU B.

ADDICTA-THE TURKISH JOURNAL ON ADDICTIONS , vol.8, pp.157-159, 2021 (ESCI)

2021

45. COVID-19 and Stigma

YILMAZ Y., ERDOĞAN A., HOCAOĞLU Ç.

ANATOLIAN JOURNAL OF CARDIOLOGY , vol.10, no.1, pp.47-55, 2021 (SCI-Expanded)

2021

46. Successful treatment with long-acting injectable aripiprazole monohydrate for two patients with dual diagnosis - substance use disorder and psychotic disorder

ERDOĞAN A., KULAKSIZOĞLU B., BİNGÖL M. S., CİNEMRE B., Kuloglu M. M.

Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , vol.34, no.1, pp.102-106, 2021 (ESCI, Scopus, TRDizin)

2021

47. Tattooing and Its Relationship with Impulsivity in Substance Use Disorder Madde Kullanım Bozukluğunda Dövme Özellikleri ve Dövmenin Dürtüsellik ile İlişkisi

ERDOĞAN A., Kara H., KÖSE F., CİNEMRE B., KULAKSIZOĞLU B., Kuloğlu M. M.

Neuropsychiatric Investigation , vol.59, no.1, pp.1-7, 2021 (Scopus)

2021

48. Distribution of Hepatitis C Virus (HCV) Genotypes Among Intravenous Drug and Non-Drug User Patients

Erman Daloglu A., PARKAN Ö. M., ERDOĞAN A., Peker B. O., Can Sarinoglu R., SAĞLIK İ., et al.

MIKROBIYOLOJI BULTENI , vol.55, no.1, pp.30-40, 2021 (SCI-Expanded, Scopus, TRDizin)

2020

49. Siberkondria: Bir Gözden Geçirme

Erdoğan A., Hocaoglu C.

CURRENT APPROACHES IN PSYCHIATRY , vol.0, 2020 (Scopus, TRDizin)

2020

50. Interstitial Lung Disease due to Quetiapine: Case Report

TOPCUOĞLU M., ERDOĞAN A.

Düzce Üniversitesi Tıp Fakültesi Dergisi , vol.22, no.2, pp.140-142, 2020 (TRDizin)

2020

51. Interstitial Lung Disease due to Quetiapine: Case Report

TOPCUOĞLU M., ERDOĞAN A.

Düzce Üniversitesi Tıp Fakültesi Dergisi , vol.22, no.2, pp.140-142, 2020 (Peer-Reviewed Journal)

2020

52. Hyponatremia due to duloxetine use in an elderly woman patient

CİNEMRE B., ERDOĞAN A., KULAKSIZOĞLU B., BİNGÖL M. S.

ORTADOĞU TIP DERGİSİ , vol.12, no.2, pp.295-298, 2020 (TRDizin)

2020

53. Cyberchondria: A Review

ERDOĞAN A., HOCAOĞLU Ç.

Psikiyatride Guncel Yaklasimlar/Current Approaches to Psychiatr , vol.12, no.4, 2020 (Scopus, TRDizin)

2020

54. Diagnosis and Treatment of Postpartum Depression: A Review

ERDOĞAN A., HOCAOĞLU Ç.

Mustafa Kemal Üniversitesi Tıp Dergisi , 2020 (Peer-Reviewed Journal)

2020

55. Psychiatric aspect of infectious diseases and pandemic: A review

ERDOĞAN A., Hocaoglu C.

KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY , vol.23, pp.72-80, 2020 (ESCI, Scopus, TRDizin)

2020

56. Personality, temperament traits and impulsivity levels in opiate use disorder patients with and without intravenous use İntravenöz kullanımı olan ve olmayan opiyat kullanım bozukluğu hastalarında kişilik, mizaç özellikleri ve dürtüsellik düzeyleri

ERDOĞAN A., CİNEMRE B., KULAKSIZOĞLU B., Kuloğlu M. M.

Yeni Symposium , vol.58, no.3, pp.2-6, 2020 (Scopus)

2020

57. Interstitial Lung Disease due to Quetiapine: Case Report and Literature Review

TOPCUOĞLU M., ERDOĞAN A.

Düzce Tıp Fak Derg , vol.22, pp.140-142, 2020 (Scopus, TRDizin)

2020

58. Comparison of oral naltrexone and naltrexone implant treatment in alcohol use disorders Alkol kullanım bozukluğunda oral naltrekson ve naltrekson implant tedavisinin karşılaştırılması

CİNEMRE B., ERDOĞAN A., KULAKSIZOĞLU B., METİN Ö., Kuloglu M. M.

Anadolu Psikiyatri Dergisi , vol.21, no.5, pp.477-482, 2020 (SCI-Expanded, Scopus, TRDizin)

2020

59. Doğum Sonrası Depresyonun Tanı ve Tedavisi: Bir Gözden Geçirme

ERDOĞAN A., HOCAOĞLU Ç.

Mustafa Kemal Üniversitesi Tıp Dergisi , vol.11, no.39, pp.31-37, 2020 (Peer-Reviewed Journal)

2019

60. Levels of TNF alpha, Soluble TNF Receptors (sTNF-R1, sTNF-R2) in Bipolar Disorder.

Baysal O. D., ERDOĞAN A., CİNEMRE B., Akbas H., Kaya S. S., Kus S.

Noro psikiyatri arsivi , vol.57, no.2, pp.136-140, 2019 (SCI-Expanded, Scopus, TRDizin)

2010

61. Bilateral Testicular Metastasis of Prostate Cancer: Case Report

PEKTAŞ F., DİLEK F. H., ATEŞ M., KARALAR M., YILDIRIM B., ERDOĞAN A., et al.

Kocatepe Tıp Dergisi , vol.11, no.1, pp.21-22, 2010 (TRDizin)

Papers Presented at Peer-Reviewed Scientific Conferences

2024

1. Çocuk Yoğun Bakım Ünitesinde Yatan Hastaların Ebeveynlerinin Akut Stres Bozukluğu, Depresyon ve Travma Sonrası Stres Bozukluğu Açısından Değerlendirilmesi

Ergün M., Ülgen Tekerek N., Dursun O., Köker A., Erdal M., Erdoğan A.

20. Ulusal Çocuk Acil Tıp ve Yoğun Bakım Kongresi ve 16. Çocuk Acil Tıp ve Yoğun Bakım Hemşireliği Kongresi, Antalya, Turkey, 27 - 30 November 2024, pp.158, (Summary Text)

2020

2. Septum Pellucidum Morfometrisinin Değerlendirilmesi

ALKAN E., ÖZ N., KARAALİ K., ERDOĞAN A., SÜZEN L. B.

21. Ulusal Anatomi Kongresi, Ankara, Turkey, 28 - 29 November 2020, pp.37-38, (Summary Text)

2020

3. BUPROPİON KULLANIMINA BAĞLI PSİKOTİK BELİRTİLERİN GÖRÜLDÜĞÜ BİR OLGU SUNUMU

BİNGÖL M. S., ERDOĞAN A.

5.PSİKİYATRİ ZİRVESİ VE 12.ANKSİYETE KONGRESİ, Antalya, Turkey, 28 - 31 October 2020, pp.304, (Full Text)

2019

4. HEPATITIS C VIRUS (HCV) GENOTYPE DISTRIBUTION AMONG INTRAVENOUS DRUG USERS (IVDU) AND HCV INFECTED PATIENTS UNRELATED TO DRUG USE

ERMAN DALOĞLU C. A., PARKAN Ö. M., ERDOĞAN A., İNAN D., KULOĞLU M. M., MUTLU D., et al.

22st ESCV (European Society for Clinical Virology), Copenhag, Denmark, 10 - 14 September 2019, pp.231, (Full Text)

2019

5. HEPATITIS C VIRUS (HCV) GENOTYPE DISTRIBUTION AMONG INTRAVENOUS DRUG USERS (IVDU) AND HCV INFECTED PATIENTS UNRELATED TO DRUG USE

ERMAN DALOĞLU C. A., PARKAN Ö. M., ERDOĞAN A., İNAN D., KULOĞLU M. M., MUTLU D., et al.

22st ESCV (European Society for Clinical Virology), Copenhag, Denmark, 10 - 14 September 2019, pp.231, (Full Text)

2019

6. HEPATITIS C VIRUS (HCV) GENOTYPE DISTRIBUTION AMONG INTRAVENOUS DRUG USERS (IVDU) AND HCV INFECTED PATIENTS UNRELATED TO DRUG USE

ERMAN DALOĞLU C. A., PARKAN Ö. M., ERDOĞAN A., İNAN D., KULOĞLU M. M., MUTLU D., et al.

22st ESCV (European Society for Clinical Virology), Copenhag, Denmark, 10 - 14 September 2019, pp.231, (Full Text)

Books

2022

1. UÇUCU MADDE KULLANIMIYLA İLIŞKILI BOZUKLUKLAR

Kara H., ERDOĞAN A.

in: ALKOL MADDE KULLANIM BOZUKLUKLARI VE DAVRANIŞSAL BAĞIMLILIKLAR , Barış YILBAŞ, Halil İbrahim ÖZTÜRK, Editor, Akademisyen Kitabevi A.Ş., Ankara, pp.201-206, 2022

2021

2. Korku-anksiyete ile ilişkili bozukluklar ve serebellum

Erdoğan A., Hocaoğlu Ç.

in: Nöropsikiyatrik Açıdan Serebellum, Behçet Coşar, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.55-60, 2021

2021

3. ZARAR AZALTMA YÖNTEMLERİ

ERDOĞAN A., KULOĞLU M. M.

in: BAĞIMLILIK TANI VE TEDAVİ TEMEL KİTABI, DİLBAZ NESRİN,GÖĞCEGÖZ IŞIL, NOYAN ONUR,KIZILKURT KAZAN ÖZLEM, Editor, Nobel Tıp Kitabevleri, pp.514-520, 2021

2021

4. ESRAR KULLANIM BOZUKLUĞU

ERDOĞAN A., HOCAOĞLU Ç.

in: BAĞIMLILIK TANI VE TEDAVİ TEMEL KİTABI, DİLBAZ NESRİN,GÖĞCEGÖZ IŞIL, NOYAN ONUR,KIZILKURT KAZAN ÖZLEM, Editor, Nobel Tıp Kitabevleri, pp.126-145, 2021

2021

5. AMİYOTROFİK LATERAL SKLEROZUN PSİKİYATRİK YÖNÜ

ERDOĞAN A., ERYILMAZ M. M.

in: NADİR HASTALIK OLARAK ALS, Hilmi Uysal, Editor, PALME YAYINLARI, pp.149-164, 2021

2020

6. COVID-19 ve İntihar

HOCAOĞLU Ç., ERDOĞAN A.

in: COVID-19 ve Psikiyatri, Behçet Çosar, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.35-42, 2020

Funded Projects

2025 - Present

Yaygın Anksiyete Bozukluğu Tanısı Alan Hastalarda Serum Alfa Klotho Protein ve NGF (Nerve Growth Factor) Düzeylerinin Sağlıklı Kontrollerle Karşılaştırılması

Project Supported by Higher Education Institutions , BAP PhD

ERDOĞAN A. (Executive), AKBAŞ S. H., ÖZEN KÜÇÜKÇETİN İ., TURAN ÖZTAŞ F. N.

2025 - Present

Major depresyon hastalarında nöronal pentraksin-2 (nptx2) düzeyleri ve ilişkili klinik faktörler

Project Supported by Higher Education Institutions , BAP PhD

ERDOĞAN A. (Executive), KULAKSIZOĞLU B., AKBAŞ S. H., Şafak E., CİNEMRE B.

2020 - Present

REPETETİF TRANSKRANİYEL MANYETİK STİMÜLASYON rTMS TEDAVİSİ ALAN DEPRESYON HASTALARINDA BDNF ProBDNF DÜZEYLERİNİN ARAŞTIRILMASI

Project Supported by Higher Education Institutions , BAP Research Project

CİNEMRE B. (Executive), KULAKSIZOĞLU S., ERDOĞAN A., BAYSAL G. Ö., UZDU A., GÜLKESEN K. H., et al.

2023 - 2025

Bipolar Bozuklukta Fibroblast Büyüme Faktörü2 FGF 2 ve Fibroblast Büyüme Faktörü9 FGF 9 Düzeyleri

Project Supported by Higher Education Institutions , BAP PhD

KULAKSIZOĞLU B. (Executive), KESKİN B., ERDOĞAN A., AKBAŞ S. H., ÖZEN KÜÇÜKÇETİN İ.

Memberships and Roles in Scientific Organizations

2025 - Present

Bağımlılık Psikiyatrisi Vakfı

Member

2015 - Present

Türkiye Psikiyatri Derneği

Member

Congress and Symposium Activities

01 December 2020 - 01 December 2020

Ulusal Psikiyatri Kongresi 2020

Attendee

Antalya-Turkey

01 October 2018 - 01 October 2018

European College of Neuropsychopharmacology ECNP 2018

Attendee

Barcelona-Spain

01 October 2017 - 01 October 2017

The WPA WORLD CONGRESS OF PSYCHIATRY 2017

Attendee

Berlin-Germany

01 April 2015 - 01 April 2015

7.Psikofarmakoloji Kongresi

Attendee

antalya-Turkey

Citations

Total Citations (WOS): 5

h-index (WOS): 1

Jury Memberships

December-2024

December 2024